NCP Flanders
choose your programme
Horizon Europe

Horizon Europe is the main Research and Innovation Funding Programme of the European Commission.

Horizon 2020

Horizon 2020 is the previous Funding Programme. There are no longer calls, but projects can run until 2024.

Digital Europe

Digital Europe is a Funding Programme focused on bringing digital technology to businesses, citizens and administrations.

Other EU Funding

There are many other relevant EU funding programmes, managed by several agencies and directorates.

Proposal writing

We guide stakeholders located in Flanders during the whole process of planning and application to a call topic. Any Flanders-based organisation can request advice from the NCP advisors free of charge.

Planning & developing of your Horizon Europe project proposal

Tips and tricks to write a good proposal as well as the steps of the evaluation process are elaborated in this video series on Proposal Writing under Horizon Europe (only for registered users).

NCP Flanders’ Infosheets offers a deep dive into specific issues and answer to frequently asked questions. Several of our infosheets can be of help for preparing your proposal.

Pre-screening & review of your proposal against the EU criteria

 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.